GlassScriptPhysician profile
Kristina Tocce
NPI 1801885330
$57,131.33
in general payments reported to CMS, 2019-2025
5 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,093 · 2020: $7,911 · 2021: $12K · 2022: $12K · 2023: $5,673 · 2024: $3,313 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,470 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,768 · Honoraria: $2,269 · Travel and Lodging: $1,476 · Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,470.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,768.19 |
| Honoraria | $2,269.17 |
| Travel and Lodging | $1,476.00 |
| Food and Beverage | $296.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $29,475.61 | 2020-2025 | |
| Organon LLC | $14,779.17 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $10,592.71 | 2019-2020 | |
| Afaxys, INC. | $2,269.17 | 2024 | |
| Abbvie INC. | $14.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristina Tocce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.